Post-traumatic stress disorder (PTSD) is a serious mental health condition that can develop after experiencing or witnessing a traumatic event. For some people, symptoms can persist for months or years and significantly affect daily life, relationships, sleep, and emotional wellbeing.
At Medicann Clinics, we support eligible UK patients who are exploring medical cannabis for PTSD as part of a carefully assessed, specialist-led treatment plan. This page explains PTSD, current treatment approaches, and how medical cannabis may help some patients manage symptoms, always under the guidance of a qualified clinician.
Medicann is a medical cannabis clinic in the UK, with free consultations for life, no repeat prescription fees, and UK same-day dispatch. If you think you may be eligible, you can check your eligibility today.
Post-traumatic stress disorder is a mental health condition triggered by exposure to trauma. According to the NHS, this may include:
PTSD can affect anyone, regardless of age or background. Symptoms may begin soon after the traumatic event or appear months or even years later.
PTSD is not a sign of weakness. It is a recognised psychological response to trauma and deserves appropriate, professional care.
PTSD symptoms are usually grouped into four main categories:
1. Re-experiencing Symptoms
2. Avoidance
3. Hyperarousal and Reactivity
4. Mood and Cognition Changes
Many patients experience overlapping symptoms, which can vary in intensity over time. PTSD often coexists with other mental health conditions, including anxiety disorders and obsessive-compulsive disorder (OCD).
In the UK, first-line PTSD treatment usually involves psychological therapies, medication, or a combination of both.
Commonly recommended approaches include:
These therapies can be highly effective, but access may be limited, and some patients find them emotionally challenging or insufficient on their own.
Doctors may prescribe:
While these treatments help many people, others experience limited benefits or unwanted side effects. Patients may begin exploring alternative options such as cannabis for PTSD through a legal, regulated pathway.
In the UK, cannabis-based medicinal products (CBPMs) can be prescribed by specialist doctors. A clinician may consider CBPMs if:
Medical cannabis does not cure PTSD, but some patients report that it may help them manage specific symptoms such as sleep disturbance, anxiety, or intrusive thoughts.
Research into medical cannabis for PTSD is ongoing, and current evidence is preliminary. However, both early studies and patient reports suggest it may help manage certain symptoms in some individuals.
Medical marijuana for PTSD interacts with the body’s endocannabinoid system, which plays a role in regulating mood, sleep, stress response, and emotional processing.
Some patients report improvements in:
Responses vary widely, and not all patients experience the same effects. Medical guidance is essential to ensure safe and effective use.
There is no single “best” treatment. Your Medicann clinician will assess your symptoms, medical history, and previous treatments before recommending an appropriate option.
Common formats include:
Some patients ask specifically about CBD oil for PTSD. While CBD-dominant products may be considered in certain cases, treatment decisions are always personalised and clinically led.
Your clinician will also carefully consider THC content, dosing, and potential interactions with other medications.
“I’ve just switched over to Medicann on a mate’s recommendation and honestly the whole thing’s been spot on. I did the eligibility check, gave them access to my medical records (all digital and dead easy), had a quick call with a lady called Lauren, and got confirmation I was eligible within a couple of hours.”
These experiences reflect individual outcomes and do not guarantee similar results for others.
Clinical evidence for medical cannabis in PTSD is still emerging.
In the UK, prescribing is carefully regulated. Medicann clinicians follow national guidance and the Cannabis Industry Council’s Good Practice Guide when assessing suitability.
Medical cannabis is often considered as part of a wider treatment plan, not a replacement for existing care.
Some patients continue to use:
Medicann works collaboratively and encourages open communication with your GP and mental health professionals where appropriate.
Yes. Medical cannabis has been legal in the UK since 2018 when prescribed by a specialist doctor for eligible patients.
Not necessarily. Your clinician will assess whether it may be used alongside existing treatments or if adjustments are appropriate.
CBD oil may be one component of medical cannabis treatment, but prescribed CBPMs are regulated medicines supplied through a legal clinical pathway.
Yes. A formal diagnosis and evidence of previous treatments are required for assessment.
(H3) How quickly could I start treatment?
Medicann offers a streamlined virtual pathway. Eligible patients may receive same-day despatch following prescription approval.
Medicann Clinics is proud to be the lowest-cost medical cannabis clinic in the UK, offering:
We are committed to fair access, transparency, and patient-centred prescribing. If PTSD symptoms are affecting your quality of life and conventional treatments have not been enough, medical cannabis may be an option worth discussing. If you have questions or would like to speak to our team, you can also contact us.
